Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

Gelijkaardige items

• Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes
  door: Hedman, Mia, et al.
  Gepubliceerd in: (2006)
• MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine
  door: Drescher, Siegfried, et al.
  Gepubliceerd in: (2002)
• No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
  door: Kalliokoski, Annikka, et al.
  Gepubliceerd in: (2008)
• Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
  door: Nies, Anne T, et al.
  Gepubliceerd in: (2013)
• The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range
  door: Kalliokoski, Annikka, et al.
  Gepubliceerd in: (2008)